ST PHARM CO., LTD. Logo

ST PHARM CO., LTD.

A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.

237690 | KO

Overview

Corporate Details

ISIN(s):
KR7237690003
LEI:
Country:
South Korea
Address:
경기도 시흥시 협력로 231(정왕동, 시화공단 1나 802호), 시흥시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ST Pharm Co., Ltd. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs) for the gene therapy market. The company is a key manufacturer of RNA-based therapeutics, with technology-driven services spanning from oligonucleotides to xRNA and mRNA. ST Pharm provides comprehensive, cGMP-compliant custom manufacturing solutions for both novel and generic drugs. With over 30 years of experience, the company supports its global partners through the entire development lifecycle, from research and development to commercial-scale production, quality control, and regulatory affairs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.3 KB
2025-09-08 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.8 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 3.4 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.6 MB
2025-08-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-07-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 119.1 KB
2025-07-24 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.8 KB
2025-07-24 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-07-18 00:00
Report Publication Announcement
결산실적공시예고
Korean 3.8 KB
2025-07-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-06-23 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 11.9 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-05-08 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 26.3 KB
2025-05-08 00:00
Remuneration Information
[기재정정]주식매수선택권부여에관한신고
Korean 32.2 KB
2025-05-08 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 28.3 KB

Automate Your Workflow. Get a real-time feed of all ST PHARM CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ST PHARM CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ST PHARM CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

YD Bio Ltd Logo
Developing blood-based cancer detection and regenerative therapies for biopharma partners.
United States of America
YDES
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea
000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan
4531
Zai Lab Ltd Logo
Global biopharma firm developing therapies for oncology, immunology, neuroscience & infectious diseases.
United States of America
ZLAB
Zealand Pharma Logo
Developing innovative peptide medicines for metabolic and inflammatory diseases.
Denmark
ZEAL
Zelluna ASA Logo
Developing off-the-shelf TCR-NK cell therapies to treat patients with solid cancers.
Norway
ULTI
Zenas BioPharma, Inc. Logo
Clinical-stage biopharma developing immunology-based therapies for autoimmune diseases.
United States of America
ZBIO
Zentalis Pharmaceuticals, Inc. Logo
Develops small molecule cancer drugs, led by a first-in-class oral WEE1 inhibitor for tumors.
United States of America
ZNTL
Zentiva 2 Logo
European provider of high-quality, affordable generic and over-the-counter medicines.
Slovakia
SKF

Talk to a Data Expert

Have a question? We'll get back to you promptly.